AKT1 and hepatocellular carcinoma: Activated AKT directly phosphorylates mTOR and activates its downstream effector molecule AP-2α, a transcription factor that drives the expression of a CSC-related molecule (CD133), which is essential for maintaining the self-renewal ability and treatment resistance of HCC cells.